logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes

Balasegaram M, Young H, Chappuis F, Priotto G, Raguenaud ME,  et al.
2008-10-21 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2008-10-21 • Transactions of the Royal Society of Tropical Medicine and Hygiene
This paper describes the effectiveness of first-line regimens for stage 2 human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense infection in nine Médecins Sans Frontièr...
Journal Article
|
Research

Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia

Raguenaud ME, Isaakidis P, Zachariah R, Te V, Soeung S,  et al.
2009-08-20 • BMC Pediatrics
2009-08-20 • BMC Pediatrics
BACKGROUND
Although HIV program evaluations focusing on mortality on ART provide important evidence on treatment effectiveness, they do not asses overall HIV program performance beca...
Journal Article
|
Research

Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola

Robays J, Raguenaud ME, Josenando T, Boelaert M
2008-02-01 • Tropical Medicine and International Health
2008-02-01 • Tropical Medicine and International Health
OBJECTIVE: To compare the cost-effectiveness of eflornithine and melarsoprol in the treatment of human African trypanosomiasis. METHOD: We used data from a Médecins Sans Frontières treat...
Journal Article
|
Research

High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia

Isaakidis P, Raguenaud ME, Te V, Tray CS, Akao K,  et al.
2010-03-21 • Journal of the International AIDS Society
2010-03-21 • Journal of the International AIDS Society
ABSTRACT: BACKGROUND: Long-term outcomes of antiretroviral therapy (ART) in children remain poorly documented in resource-limited settings. The objective of this study was to assess two-...